❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ Dept. of Tumor Biology ❭ Eivind Hovig's group ❭ Research interests ❭ Links ❭
  • Search
  • Publication search
  • Print page

Links

Microarrays

University of Oslo microarray core facility

National Microarray Consortium

The BASE official site

Bioinformatics

Pubgene

Clincial bioinformatics collaboration in the Oslo region

FUGE National bioinformatics platform

Statistical bioinformatics at NR

Torbjørn Rognes at The National Hospital in Oslo

Norwegian Chemometrics Society

Home Dept. of Tumor Biology Eivind Hovig's group

  • Eivinds work calendar
  • Total staff list
  • Wet-lab group
  • DNR Bioinformatics
  • Research interests
    • Mutation analysis
    • Gene therapy
    • DNA variation
    • Links
  • Publications
  • Company affiliations
  • Press (mostly in Norw.)
  • Inherited and Familial Cancer [Dominguez-Valentin]
  • Genomic Regulation for Precision Cancer Medicine Lab [Urbanucci]
  • Autophagy in cancer [Engedal]
  • DNA analysis and methods [Ekstrøm]

Recent publications

Cao S, Wang JR, Ji S, Yang P, Dai Y, Guo S, Montierth MD, Shen JP, Zhao X, Chen J, Lee JJ, Guerrero PA, Spetsieris N, Engedal N, Taavitsainen S, Yu K, Livingstone J, Bhandari V, Hubert SM, Daw NC, Futreal PA, Efstathiou E, Lim B, Viale A, Zhang J et al. (2022)
Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression
Nat Biotechnol (in press)
DOI 10.1038/s41587-022-01342-x, PubMed 35697807

Misund K, Hofste Op Bruinink D, Coward E, Hoogenboezem RM, Rustad EH, Sanders MA, Rye M, Sponaas AM, van der Holt B, Zweegman S, Hovig E, Meza-Zepeda LA, Sundan A, Myklebost O, Sonneveld P, Waage A (2022)
Clonal evolution after treatment pressure in multiple myeloma: heterogenous genomic aberrations and transcriptomic convergence
Leukemia (in press)
DOI 10.1038/s41375-022-01597-y, PubMed 35643867

Ellingsen EB, Aamdal E, Guren T, Lilleby W, Brunsvig PF, Mangsbo SM, Aamdal S, Hovig E, Mensali N, Gaudernack G, Inderberg EM (2022)
Durable and dynamic hTERT immune responses following vaccination with the long-peptide cancer vaccine UV1: long-term follow-up of three phase I clinical trials
J Immunother Cancer, 10 (5)
DOI 10.1136/jitc-2021-004345, PubMed 35613827



More publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Email: trond.olav.berg@rr-research.no

Cookie policy